Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

È«ÇòÊ׸ö£¡Åµ»ª°¢ÇúÉú̹»ñÅúÉÏÊУ¬£¬£¬£¬£¬ÖÎÁÆ IgA Éö²¡ | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2025-04-03
|
»á¼ûÁ¿£º

0404.jpgÒ½ÏßÒ©ÎÅ

1. 4ÔÂ3ÈÕ£¬£¬£¬£¬£¬Åµ»ªÐû²¼Æä¸ßÑ¡ÔñÐÔÄÚÆ¤ËØAÊÜÌ壨ETA£©Þ׿¹¼Á°¢ÇúÉú̹£¨atrasentan£¬£¬£¬£¬£¬Vanrafia£©µÄÉÏÊÐÉêÇëÒÑ»ñFDA¼ÓËÙÅú×¼£¬£¬£¬£¬£¬ÓÃÓÚ½µµÍÓм²²¡Ï£ÍûΣº¦µÄÔ­·¢ÐÔÃâÒßÇòÂѰ×AÉö²¡£¡£¡£¡£¡£¡£¨IgAN£©³ÉÈË»¼ÕßµÄÂѰ×Äò¡£¡£¡£¡£¡£¡£ÕâÒâζ×Å£¬£¬£¬£¬£¬°¢ÇúÉú̹³ÉΪÁËÊ׸ö»ñÅúÓÃÓÚïÔÌ­Ô­·¢ÐÔIgAÉö²¡ÂѰ×ÄòµÄÑ¡ÔñÐÔETAÞ׿¹¼Á¡£¡£¡£¡£¡£¡£

2. 4ÔÂ3ÈÕ£¬£¬£¬£¬£¬CDE¹ÙÍø¹«Ê¾£¬£¬£¬£¬£¬ÈýÉú¹ú½¡É걨µÄ1ÀàÐÂÒ©SSGJ-627×¢ÉäÒº»ñÅúÁÙ´²£¬£¬£¬£¬£¬Ä⿪·¢ÖÎÁÆÀ£ÑñÐԽ᳦Ñ×£¨UC£©¡£¡£¡£¡£¡£¡£Æ¾Ö¤ÈýÉú¹ú½¡¹ûÈ»×ÊÁÏ£¬£¬£¬£¬£¬ÕâÊÇÒ»¿î¿¹TL1Aµ¥¿¹¡£¡£¡£¡£¡£¡£±¾´ÎÊǸòúÆ·Ê×´ÎÔÚÖйú»ñÅúÁÙ´²¡£¡£¡£¡£¡£¡£

3. 4ÔÂ2ÈÕ£¬£¬£¬£¬£¬CDE¹ÙÍø¹«Ê¾£¬£¬£¬£¬£¬°¢Ë¹Àû¿µ£¨AstraZeneca£©É걨µÄ1ÀàÐÂÒ©AZD5492ÔÚÖйú»ñÅúÁ½ÏîеÄÁÙ´²ÊÔÑéĬʾÔÊÐí£¬£¬£¬£¬£¬ÄâÓÃÓÚÖÎÁÆÏµÍ³ÐÔºì°ßÀÇ´¯¡¢ÌØ·¢ÐÔÑ×Ö¢ÐÔ¼¡²¡¡£¡£¡£¡£¡£¡£¹ûÈ»×ÊÁÏÏÔʾ£¬£¬£¬£¬£¬ÕâÊÇÒ»¿îCD20¡ÁTCR¡ÁCD8ÈýÌØÒìÐÔ¿¹Ì壬£¬£¬£¬£¬ÊÇÓÉCD8Ö¸µ¼µÄTϸ°ûÏÎ½ÓÆ÷£¨TCE£©¡£¡£¡£¡£¡£¡£

4. 4ÔÂ3ÈÕ£¬£¬£¬£¬£¬¾ÝCDE¹ÙÍøÐÂÎÅ£¬£¬£¬£¬£¬¹ã¶«Ë«ÁÖÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾ÁªºÏÉêÇëÒ©Æ·¡°¾²×¢ÈËÃâÒßÇòÂѰ×(10%) ¡±£¬£¬£¬£¬£¬»ñµÃÁÙ´²ÊÔÑéĬʾÔÊÐí£¬£¬£¬£¬£¬Ë³Ó¦Ö¢£ºÂýÐÔÑ×ÐÔÍÑËèÇÊÐÔ¶à·¢ÐÔÉñ¾­¸ùÉñ¾­²¡£¡£¡£¡£¡£¡£¨CIDP£©¡£¡£¡£¡£¡£¡£

ͶÈÚÒ©ÊÂ

1. 3ÔÂ30ÈÕ£¬£¬£¬£¬£¬ÅÉÁÖÉúÎïͨ¸æ³Æ£¬£¬£¬£¬£¬¹«Ë¾Óë¾§Ì©¿Ø¹ÉÇ©ÊðÕ½ÂÔÏàÖúЭÒ飬£¬£¬£¬£¬ÏàÖú¹æÄ£Ô¼1ÒÚÔª£¬£¬£¬£¬£¬ÏàÖúÆÚ5Ä꣬£¬£¬£¬£¬ÆÚÂúºóÖª×ãÌõ¼þ¿É×Ô¶¯ÑÓÐøÁ½Äê¡£¡£¡£¡£¡£¡£Æ¾Ö¤Ð­Ò飬£¬£¬£¬£¬Ë«·½½«¾Û½¹Ò©Æ·Ñз¢ÓÅ»¯¡¢Éú²úÖÊÁ¿ÖÇÄÜ»¯¹ÜÀí¼°ÂѰ×ÖʽṹÑо¿Èý´óÁìÓò£¬£¬£¬£¬£¬ÅäºÏÍÆ¶¯ÑªÒºÖÆÆ·Ñз¢Ð§ÂÊÌáÉýÓë²úÆ·Éý¼¶¡£¡£¡£¡£¡£¡£Í¨¸æÌáµ½£¬£¬£¬£¬£¬´Ë´ÎÏàÖú¶ÌÆÚÄÚ²»»á¶Ô¹«Ë¾²ÆÎñ¼°Ä±»®Òµ¼¨±¬·¢ÖØ´óÓ°Ï죬£¬£¬£¬£¬Î´À´ÏêÏ¸Ð§ÒæÐèÊÓÏîÄ¿Â䵨ÇéÐζø¶¨¡£¡£¡£¡£¡£¡£

¿Æ¼¼Ò©ÑÐ

1. ¿ËÈÕ£¬£¬£¬£¬£¬ÖÐɽ´óѧ´ÞöÁ½ÌÊÚÍŶÓ£¬£¬£¬£¬£¬ÔÚ Nature ×Ó¿¯ Nature Cancer ÉϽÒÏþÁËÌâΪ£ºPalmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity µÄÑо¿ÂÛÎÄ¡£¡£¡£¡£¡£¡£Ñо¿Õ¹ÏÖÁË zDHHC8 ͨ¹ý¶Ô GPX4 µÄרéµõ£»£»£»£» £»¯ÐÞÊΣ¬£¬£¬£¬£¬´Ó¶ø±ÜÃâÌúéæÃü£¬£¬£¬£¬£¬¸ÃÑо¿½øÒ»²½É¸Ñ¡ÁË zDHHC8 µÄÌØÒìÐÔÒÖÖÆ¼Á¡ª¡ªPF-670462£¬£¬£¬£¬£¬Äܹ»Ôö½øÖ×Áöϸ°ûÌúéæÃü²¢Ìá¸ß°©Ö¢ÃâÒßÖÎÁÆÐ§¹û¡£¡£¡£¡£¡£¡£

[1]Zhou, L., Lian, G., Zhou, T. et al. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. Nat Cancer (2025). https://doi.org/10.1038/s43018-025-00937-y

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿